Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Narrative) (Details)

v3.23.1
Stockholders' Equity (Narrative) (Details)
Dec. 01, 2022
shares
Oct. 07, 2022
Aug. 23, 2022
shares
May 09, 2022
USD ($)
$ / shares
shares
Oct. 31, 2021
$ / shares
Feb. 23, 2017
USD ($)
shares
Mar. 31, 2023
$ / shares
shares
Dec. 06, 2022
shares
Jul. 19, 2022
shares
Jun. 30, 2022
$ / shares
shares
Nov. 01, 2021
$ / shares
shares
Stockholders' Equity [Line Items]                      
Preferred Stock, shares authorized       1,000,000   1,000,000 1,000,000     1,000,000  
Preferred stock, shares outstanding (in shares)             0     1,000  
Preferred stock, par value (in dollars per share) | $ / shares       $ 0.001     $ 0.001     $ 0.001  
Common stock, shares authorized (in shares)             275,000,000     275,000,000  
Stockholders' Equity Note, Stock Split, Conversion Ratio   0.04                  
College Station Investors LLC And Bryan Capital [Member]                      
Stockholders' Equity [Line Items]                      
Warrants, exercise price per share | $ / shares                     $ 33.25
Warrants to purchase shares of Common Stock                     51,583
H.C. Wainwright & Co., LLC [Member]                      
Stockholders' Equity [Line Items]                      
Warrants to purchase shares of Common Stock               201,923      
Pre Funded Warrants [Member] | H.C. Wainwright & Co., LLC [Member]                      
Stockholders' Equity [Line Items]                      
Warrants, exercise price per share | $ / shares             $ 0.001        
Series A Warrants [Member] | H.C. Wainwright & Co., LLC [Member]                      
Stockholders' Equity [Line Items]                      
Warrants, exercise price per share | $ / shares             $ 1.04        
Term of the warrants             5 years        
Warrants to purchase shares of Common Stock               504,807      
Series B Warrants [Member] | H.C. Wainwright & Co., LLC [Member]                      
Stockholders' Equity [Line Items]                      
Warrants, exercise price per share | $ / shares             $ 1.04        
Term of the warrants             2 years        
Warrants to purchase shares of Common Stock               504,807      
Representative Warrants [Member] | H.C. Wainwright & Co., LLC [Member]                      
Stockholders' Equity [Line Items]                      
Warrants, exercise price per share | $ / shares             $ 1.30        
Term of the warrants             5 years        
iBio CMO Preferred Tracking Stock [Member]                      
Stockholders' Equity [Line Items]                      
Preferred Stock, Dividend Rate, Percentage           2.00%          
Preferred Stock, Dividends Per Share, Declared | $ / shares         $ 0            
Preferred stock, shares outstanding (in shares)                     0
Series 2022 Convertible Preferred Stock [Member]                      
Stockholders' Equity [Line Items]                      
Proceeds from sale of shares, net of issuance cost | $       $ 270              
Shares issued upon conversion                 40    
Shares issued       1,000              
Stockholders' Equity Note, Stock Split, Conversion Ratio       1              
Restricted Stock Units [Member]                      
Stockholders' Equity [Line Items]                      
Shares vested 4,120   1,057                
Omnibus Incentive (the 2020) Plan [Member]                      
Stockholders' Equity [Line Items]                      
Shares available for grant under the plan             1,280,000        
Exchange Agreement [Member] | iBio CMO Preferred Tracking Stock [Member] | Bioprocessing (iBio CDMO) [Member]                      
Stockholders' Equity [Line Items]                      
Stock Issued During Period, Shares, Acquisitions           1          
Number of LLC interest units exchanged for each share of preferred tracking stock           29,990,000          
Proceeds from sale of shares, net of issuance cost | $           $ 13,000,000          
Exchange Agreement [Member] | iBio CMO Preferred Tracking Stock [Member] | After Preferred Tracking Stock Exchanged for Units of Limited Liability Company Interests [Member] | Bioprocessing (iBio CDMO) [Member]                      
Stockholders' Equity [Line Items]                      
Noncontrolling Interest, Ownership Percentage by Parent           99.99%          
Exchange Agreement [Member] | Eastern Affiliate [Member] | iBio CMO Preferred Tracking Stock [Member] | After Preferred Tracking Stock Exchanged for Units of Limited Liability Company Interests [Member] | Bioprocessing (iBio CDMO) [Member]                      
Stockholders' Equity [Line Items]                      
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners           0.01%